Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
Eur J Nucl Med Mol Imaging
.
2020 Oct;47(11):2493-2498.
doi: 10.1007/s00259-020-04697-y.
Authors
Austin J Borja
1
2
,
Emily C Hancin
1
3
,
Vincent Zhang
1
,
Mona-Elisabeth Revheim
1
4
5
,
Abass Alavi
6
Affiliations
1
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
2
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
3
Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
4
Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
5
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
6
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
[email protected]
.
PMID:
31982989
DOI:
10.1007/s00259-020-04697-y
No abstract available
Publication types
Editorial
MeSH terms
Cerebrovascular Disorders* / diagnostic imaging
Dementia* / diagnostic imaging
Fluorodeoxyglucose F18
Humans
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Substances
Fluorodeoxyglucose F18